Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: A population-based analysis of 6271 cases

Cancer

Volumn 121, Issue 13, 2015, Pages 2214-2221

  Hallet, Julie ^a,b   Law, Calvin H L ^a,b   Karanicolas, Paul J ^a,b   Saskin, Refik ^c   Liu, Ning ^c   Singh, Simron ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Institute of Clinical and Evaluative Sciences   (Canada)

Author keywords

carcinoid; incidence; neuroendocrine; outcomes; rural

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANADA; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; URBAN RURAL DIFFERENCE; HEALTH CARE DELIVERY; HEALTH DISPARITY; INCIDENCE; MIDDLE AGED; MORTALITY; NEUROENDOCRINE TUMORS; ONTARIO; PROSPECTIVE STUDY; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URBAN POPULATION;

AGED; COHORT STUDIES; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MIDDLE AGED; NEUROENDOCRINE TUMORS; ONTARIO; PROSPECTIVE STUDIES; RURAL POPULATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URBAN POPULATION;

EID: 84931028452     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29338     Document Type: Article

References (41)

1. Ellis L, Shale MJ, Coleman MP,. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol. 2010; 105: 2563-2569.
2. Yao JC, Hassan M, Phan A, et al., One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008; 26: 3063-3072.
3. Modlin IM, Lye KD, Kidd M,. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97: 934-959.
4. Hallet J, Law C, Cukier M, Saskin R, Liu N, Singh S,. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015; 121: 589-597.
5. Modlin IM, Oberg K, Chung DC, et al., Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008; 9: 61-72.
6. Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E,. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst. 2008; 100: 1282-1289.
7. Dalton SO, Ross L, During M, et al., Influence of socioeconomic factors on survival after breast cancer-a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983-1999. Int J Cancer. 2007; 121: 2524-2531.
8. Fraenkel M, Kim MK, Faggiano A, Valk GD,. Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012; 26: 691-703.
9. Doll R,. Urban and rural factors in the aetiology of cancer. Int J Cancer. 1991; 47: 803-810.
10. Modlin IM, Champaneria MC, Chan AKC, Kidd M,. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol. 2007; 102: 1464-1473.
11. Twelves CJ, Thomson CS, Dewar JA, Brewster DH,. Variation in survival of women with breast cancer: health board remains a factor at 10 years. Br J Cancer. 2001; 85: 637-640.
12. Oberndorfer F,. Karzinoide Tumoren des Dunndarms. Frankf Z Pathol. 1907; 1: 426-432.
13. Obertova Z, Brown C, Holmes M, Lawrenson R,. Prostate cancer incidence and mortality in rural men-a systematic review of the literature. Rural Remote Health. 2012; 12: 2039.
14. Jong KE, Smith DP, Yu XQ, O'Connell DL, Goldstein D, Armonstrong BK,. Remoteness of residence and survival from cancer in New South Wales. Med J Aust. 2004; 180: 618-622.
15. Institute for Clinical Evaluative Sciences. http://www.ices.on.ca/. Accessed January 2014.
16. Health Canada. Canada Health Act. http://www.hc-sc.gc.ca/hcs-sss/medi-assur/cha-lcs/index-eng.php. Accessed December 2014.
17. Robles SC, Marrett LD, Clarke EA, Risch HA,. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988; 41: 495-501.
18. Clarke EA, Marrett LD, Kreiger N,. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991: 246-257.
19. Holowaty EJ, Dale D,. The hospital-only project. Health Rep. 1993; 5: 91-95.
20. Paszat LF, Brundage MD, Groome PA, Schulze K, Mackillop WJ,. A population-based study of rectal cancer: permanent colostomy as an outcome. Radiat Oncol Biol. 1999; 45: 1185-1191.
21. Juurlink D, Preyra C, Croxford R,. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. Toronto, Canada: Institute for Clinical Evaluative Sciences; 2006.
22. Du Plessis V, Beshiri R, Bollman R,. Definitions of "rural". Rural Small Town Canada Anal Bull. 2013; 3: 1-43.
23. Wilkins R,. Use of postal codes and addresses in the analysis of health data. Health Rep. 1993; 5: 157-177.
24. Johns Hopkins ACG System. http://acg.jhsph.org/. Accessed January 2014.
25. Starfield B, Weiner JP, Mumford LM,. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991; 26: 53-74.
26. Launoy G, Le Coutour X, Gignoux M, Pottier D, Dugleux G,. Influence of rural environment on diagnosis, treatment, and prognosis of colorectal cancer. J Clin Epidemiol. 1992; 46: 365-367.
27. Leung J, McKenzie S, Martin J, McLaughlin D,. Effect of rurality on screening for breast cancer: a systematic review and meta-analysis comparing mammography. Rural Remote Health. 2014; 14: 2730.
28. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J,. Rural and urban differences in stage at diagnosis of colorectal and lung cancers. Br J Cancer. 2001; 84: 910-914.
29. Aguilar I, Compes L, Feja C, Rabanaque MJ, Martos C,. Gastric cancer incidence and geographical variations: the influence of gender and rural and socioeconomic factors, Zaragoza (Spain). Gastric Cancer. 2013; 16: 245-253.
30. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM,. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer. 2005; 104: 2292-2309.
31. Vakonaki E, Androutsopoulos VP, Liesivuori J, Tsatsakis AM, Spandidos DA,. Pesticides and oncogenic modulation. Toxicology. 2013; 307: 42-45.
32. Cheung MR,. Low income and rural county of residence increase mortality from bone and joint sarcomas. Asian Pac J Cancer Prev. 2013; 14: 5043-5047.
33. Cheung MR,. Racial and social economic factors impact on the cause specific survival of pancreatic cancer: a SEER survey. Asian Pac J Cancer Prev. 2013; 14: 159-163.
34. Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA,. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001; 93: 1344-1346.
35. Singh S, Law C,. Multidisciplinary reference centers: the care of neuroendocrine tumors. J Oncol Pract. 2010; 6: e11-e16.
36. Campbell NC, Elliott AM, Sharop L, Ritchie LD, Cassidy J, Little J,. Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer. 2000; 82: 1863-1866.
37. Booth C, Li G, Zhang-Salomons J, Mackillop WJ,. The impact of socioeconomic status on stage of cancer at diagnosis and survival. Cancer. 2010; 116: 4160-4167.
38. Terashima M, Rainham DGC, Levy AR,. A small-area analysis of inequalities in chronic disease prevalence across urban and non-urban communities in the province of Nova Scotia, Canada, 2007-2011. BMJ Open. 2014; 4: e004459.
39. Ohrvall U, Eriksson B, Juhlin C, et al., Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg. 2014; 24: 1402-1408.
40. Mustard CA, Derksen S, Berthelot JM, Wofson M,. Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status. Health Place. 1999; 5: 157-171.
41. Kriger N,. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992; 82: 703-710.